Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Antiinfective API Market Size Growth Rate by Type
1.3.2 Respiratory Infections API
1.3.3 Skin Infections API
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Antiinfective API Market Share by Application (2019-2025)
1.4.2 Oral Medicine
1.4.3 Injection
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Antiinfective API Production Value 2014-2025
2.1.2 Global Antiinfective API Production 2014-2025
2.1.3 Global Antiinfective API Capacity 2014-2025
2.1.4 Global Antiinfective API Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Antiinfective API Market Size CAGR of Key Regions
2.2.2 Global Antiinfective API Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Antiinfective API Capacity by Manufacturers
3.1.2 Global Antiinfective API Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Antiinfective API Revenue by Manufacturers (2014-2019)
3.2.2 Antiinfective API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Antiinfective API Market Concentration Ratio (CR5 and HHI)
3.3 Antiinfective API Price by Manufacturers
3.4 Key Manufacturers Antiinfective API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Antiinfective API Market
3.6 Key Manufacturers Antiinfective API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Respiratory Infections API Production and Production Value (2014-2019)
4.1.2 Skin Infections API Production and Production Value (2014-2019)
4.1.3 Other Production and Production Value (2014-2019)
4.2 Global Antiinfective API Production Market Share by Type
4.3 Global Antiinfective API Production Value Market Share by Type
4.4 Antiinfective API Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Antiinfective API Consumption by Application
6 Production by Regions
6.1 Global Antiinfective API Production (History Data) by Regions 2014-2019
6.2 Global Antiinfective API Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaAntiinfective API Production Growth Rate 2014-2019
6.3.2 North America Antiinfective API Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Antiinfective API Import & Export
6.4 Europe
6.4.1 Europe Antiinfective API Production Growth Rate 2014-2019
6.4.2 Europe Antiinfective API Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Antiinfective API Import & Export
6.5 China
6.5.1 China Antiinfective API Production Growth Rate 2014-2019
6.5.2 China Antiinfective API Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Antiinfective API Import & Export
6.6 Japan
6.6.1 Japan Antiinfective API Production Growth Rate 2014-2019
6.6.2 Japan Antiinfective API Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Antiinfective API Import & Export
7 Antiinfective API Consumption by Regions
7.1 Global Antiinfective API Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Antiinfective API Consumption by Type
7.2.2 North America Antiinfective API Consumption by Application
7.2.3 North America Antiinfective API Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Antiinfective API Consumption by Type
7.3.2 Europe Antiinfective API Consumption by Application
7.3.3 Europe Antiinfective API Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Antiinfective API Consumption by Type
7.4.2 Asia Pacific Antiinfective API Consumption by Application
7.4.3 Asia Pacific Antiinfective API Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Antiinfective API Consumption by Type
7.5.2 Central & South America Antiinfective API Consumption by Application
7.5.3 Central & South America Antiinfective API Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Antiinfective API Consumption by Type
7.6.2 Middle East and Africa Antiinfective API Consumption by Application
7.6.3 Central & South America Antiinfective API Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 ACS Dobfar
8.1.1 ACS Dobfar Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Antiinfective API
8.1.4 Antiinfective API Product Introduction
8.1.5 ACS Dobfar Recent Development
8.2 Sterile India
8.2.1 Sterile India Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Antiinfective API
8.2.4 Antiinfective API Product Introduction
8.2.5 Sterile India Recent Development
8.3 Nectar Lifesciences
8.3.1 Nectar Lifesciences Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Antiinfective API
8.3.4 Antiinfective API Product Introduction
8.3.5 Nectar Lifesciences Recent Development
8.4 Kopran
8.4.1 Kopran Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Antiinfective API
8.4.4 Antiinfective API Product Introduction
8.4.5 Kopran Recent Development
8.5 Qilu Pharmaceutial
8.5.1 Qilu Pharmaceutial Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Antiinfective API
8.5.4 Antiinfective API Product Introduction
8.5.5 Qilu Pharmaceutial Recent Development
8.6 Hangzhou Viwa
8.6.1 Hangzhou Viwa Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Antiinfective API
8.6.4 Antiinfective API Product Introduction
8.6.5 Hangzhou Viwa Recent Development
8.7 Daewoong Bio
8.7.1 Daewoong Bio Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Antiinfective API
8.7.4 Antiinfective API Product Introduction
8.7.5 Daewoong Bio Recent Development
8.8 Fresenius Kabi iPSUM
8.8.1 Fresenius Kabi iPSUM Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Antiinfective API
8.8.4 Antiinfective API Product Introduction
8.8.5 Fresenius Kabi iPSUM Recent Development
8.9 Sinopharm Weiqida Pharmaceutical
8.9.1 Sinopharm Weiqida Pharmaceutical Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Antiinfective API
8.9.4 Antiinfective API Product Introduction
8.9.5 Sinopharm Weiqida Pharmaceutical Recent Development
8.10 Virchow Healthcare
8.10.1 Virchow Healthcare Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Antiinfective API
8.10.4 Antiinfective API Product Introduction
8.10.5 Virchow Healthcare Recent Development
8.11 United Laboratories International Holdings
8.12 Dawnrays
8.13 CSPC Pharmaceutical
8.14 Orchid Pharma
8.15 Guangzhou Pi & Pi Biotech
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Antiinfective API Capacity, Production Forecast 2019-2025
9.1.2 Global Antiinfective API Production Value Forecast 2019-2025
9.2 Antiinfective API Production and Production Value Forecast by Regions
9.2.1 Global Antiinfective API Production Value Forecast by Regions
9.2.2 Global Antiinfective API Production Forecast by Regions
9.3 Antiinfective API Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Antiinfective API Production Forecast by Type
9.4.2 Global Antiinfective API Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Antiinfective API Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Antiinfective API Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Antiinfective API Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Antiinfective API Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Antiinfective API Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Antiinfective API Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Antiinfective API Sales Channels
11.2.2 Antiinfective API Distributors
11.3 Antiinfective API Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
【掲載企業】
ACS Dobfar、Sterile India、Nectar Lifesciences、Kopran、Qilu Pharmaceutial、Hangzhou Viwa、Daewoong Bio、Fresenius Kabi iPSUM、Sinopharm Weiqida Pharmaceutical、Virchow Healthcare、United Laboratories International Holdings、Dawnrays、CSPC Pharmaceutical、Orchid Pharma、Guangzhou Pi & Pi Biotech